Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
A very strong showing by Bio-Techne Corp. today, with an increase of €2.63 (6.520%) compared to yesterday's price.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 60 € shows a positive potential of 38.28% compared to the current price of 43.39 € for Bio-Techne Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Bio-Techne Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 6.520% | -7.955% | -6.568% | 0.440% | -13.220% | -42.530% | - |
| Haemonetics Corp. | 2.940% | -12.157% | -9.312% | - | -34.599% | - | - |
| Bio-Rad Labs Inc. A | 0.730% | -8.047% | -8.735% | 6.660% | -14.928% | -37.207% | -56.120% |
| CONMED Corp. | 0.000% | 1.935% | 6.040% | -35.510% | -9.714% | -71.532% | -73.220% |
Comments
Bio-Techne (TECH) had its price target lowered by Citigroup Inc. from $80.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its price target lowered by Wells Fargo & Company from $76.00 to $62.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat